1,024
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies

, , , , &
Pages 829-841 | Received 10 Jan 2016, Accepted 08 Mar 2016, Published online: 06 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Aurelia Markezana, Muneeb Ahmed, Gaurav Kumar, Elina Zorde-Khvalevsky, Nir Rozenblum, Eithan Galun & S. Nahum Goldberg. (2020) Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity. International Journal of Hyperthermia 37:1, pages 119-129.
Read now
Muneeb Ahmed, Gaurav Kumar, Svetlana Gourevitch, Tatyana Levchenko, Eithan Galun, Vladimir Torchilin & S. Nahum Goldberg. (2018) Radiofrequency ablation (RFA)-induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins. International Journal of Hyperthermia 34:7, pages 934-942.
Read now
Rui Li, Xiaoxi Kou, Lihui Zhang & Shaojin Wang. (2018) Inactivation kinetics of food-borne pathogens subjected to thermal treatments: a review. International Journal of Hyperthermia 34:2, pages 177-188.
Read now

Articles from other publishers (3)

Carlos Caro, Mehrab Pourmadadi, Mohammad Mahdi Eshaghi, Erfan Rahmani, Shirin Shojaei, Ana Cláudia Paiva-Santos, Abbas Rahdar, Razieh Behzadmehr, Maria Luisa García-Martín & Ana M. Díez-Pascual. (2022) Nanomaterials loaded with Quercetin as an advanced tool for cancer treatment. Journal of Drug Delivery Science and Technology 78, pages 103938.
Crossref
Nicole F. Bonan, Debbie K. Ledezma, Matthew A. Tovar, Preethi B. Balakrishnan & Rohan Fernandes. (2022) Anti-Fn14-Conjugated Prussian Blue Nanoparticles as a Targeted Photothermal Therapy Agent for Glioblastoma. Nanomaterials 12:15, pages 2645.
Crossref
Macy Payne, Stefan H. Bossmann & Matthew T. Basel. (2020) Direct treatment versus indirect: Thermo‐ablative and mild hyperthermia effects . WIREs Nanomedicine and Nanobiotechnology 12:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.